|
Šimůnek T., Štěrba M., Popelová O., Kaiserová H., Adamcová M., Hroch M., Hašková P., Ponka P., Geršl V.:
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.
British Journal of Pharmacology 155 (1): 138-48, 2008.
Šimůnek T., Štěrba M., Popelová O., Kaiserová H., Potáčová A., Adamcová M., Mazurová Y., Ponka P., Geršl V.:
Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity.
Hemoglobin 32 (1-2): 207-15, 2008.
Kaiserová H., Šimůnek T., Štěrba M., den Hartog G.J.M., Schröterová L., Popelová O., Geršl V., Kvasničková E., Bast A.:
New iron chelators in anthracycline-induced cardiotoxicity.
Cardiovascular Toxicology 7 (2): 145-50, 2007.
Adamcová M., Šimůnek T., Kaiserová H., Popelová O., Štěrba M., Potáčová A., Vávrová J., Maláková J., Kvasničková E., Geršl V.:
In vitro and in vivo examination of Cardiac troponins as biochemical markers of anthracycline-induced cardiotoxicity.
Toxicology 237 (1-3): 218-28, 2007.
Kaiserová H., Šimůnek T., van der Vijgh W.J.F., Bast A., Kvasničková E.:
Flavonoids as protectants against doxorubicin cardiotoxicity: role of iron chelation, antioxidant activity and inhibition of carbonyl reductases.
Biophysica Biochimica Acta 1772 (9): 1065-74, 2007.
Štěrba M., Popelová O., Šimůnek T., Mazurová Y., Potáčová A., Adamcová M., Guncova I., Kaiserová H., Palička V., Ponka P., Geršl V.:
Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH).
Toxicology 253 (3): 150-66, 2007.
Bast A., Kaiserová H., den Hartog G.J.M., Haenen G.R.M.M., van der Vijgh W.J.F.:
Protectors against doxorubicin-induced cardiotoxicity: Flavonoids.
Cell Biology and Toxicology 23 (1): 39-47, 2007.
Kaiserová H., den Hartog G.J.M., Šimůnek T., Schröterová L., Kvasničková E., Bast A.:
Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
British Journal of Pharmacology 149 (7): 920-930, 2006.
Štěrba M., Popelová O., Šimůnek T., Mazurová Y., Potáčová A., Adamcová M., Kaiserová H., Ponka P., Geršl V.:
Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity.
Journal of Pharmacology and Experimental Therapy 319 (3): 1336-47, 2006.
Kaiserová H., Kvasničková E.:
Inhibition study of rabbit liver cytosolic reductases involved in daunorubicin toxication.
Journal of Enzyme Inhibition and Medicinal Chemistry 20 (5): 477-483, 2005.
Schröterová L., Kaiserová H., Baliharová V., Velík J., Geršl V., Kvasničková E.:
The effect of new lipophilic chelators on activities of cytosolic reductases and P450 cytochromes involved in the metabolism of anthracycline antibiotics. Studies in vitro.
Physiological Research 53 (6): 683-91, 2004.
|
